![]() |
市場調查報告書
商品編碼
1847192
中國牙科植入市場:市場規模、佔有率和趨勢分析(2025-2031年)Dental Implants Market Size, Share & Trends Analysis | China | 2025-2031 | Includes: Dental Implants, Dental Final Abutments, and 3 more |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
2024年中國人工植牙和最終支台齒市場規模約為6.04億美元,預計2031年將成長至超過13億美元。
本報告涵蓋人工植牙、最終支台齒、治療計畫軟體和手術範本。
量化目標包括銷售量、平均售價、市場規模、成長率和企業市場占有率。
它還對市場促進因素、近期併購、公司簡介、產品系列以及牙科連鎖店、專科醫院和獨立診所的競爭定位進行了定性分析。
中國的一項關鍵政策力量是基於價值的採購(VBP),其目標是透過將需求整合到符合較低單價的競標中來降低實際支出成本。
短期影響是植入位體的 ASP 壓縮,以及在較小程度上與獲獎生態系相關的支台齒ASP 壓縮。
中期來看,情況則更為平衡:如果競標擴大了患者的就醫管道,使診所能夠處理更多病例,那麼手術量將會增加,從而有助於抵消整個市場的價格下降。
將產品組合、教育和服務與價值導向產品 (VBP) 成果相匹配的供應商,最有利於在保持市場佔有率的同時參與銷售量成長。
市場概覽
推動中國植入市場發展的三大動力是:首先是患者需求,他們追求美觀、功能性,並且擁有龐大的部分牙列缺失成年人群體;其次是醫療服務規模的擴大,牙科服務機構和專科牙科醫院數量迅速成長,不斷擴大服務能力並增設植入牙診療椅;第三是政策和定價,以價值導向醫療支付(VBP)為核心,旨在降低醫療成本。
臨床上,核心平台由植入骨骼的鈦金屬植體和連接植體與牙冠或義齒的最終支台齒組成。基於此平台,CBCT成像、電腦輔助手術和CAD/CAM支台齒在主要城市中心和學術中心的應用正在穩步推進。這些工具提高了手術精度,縮短了就診時間,並減少了返工。然而,對於預算有限的小型診所而言,投資掃描器、軟體和提升醫護人員技能的需求可能會減緩這些技術的應用。
購買人群構成至關重要。像亞瑞牙科集團、拜博牙科集團和嘉美牙科集團這樣的私人牙科連鎖機構正在不斷擴張其網路。連鎖機構可以標準化系統、協商更優惠的價格,並在所有門市實施教育培訓計畫。獨立診所則更注重可靠性、配件供應以及當地經銷商的支援。牙科專科醫院則專注於處理複雜病例,並為學員提供高級工作流程培訓,包括導板手術和客製化支台齒。
市場促進因素
輔助技術的進步。錐形束CT掃描儀和規劃軟體的興起,為精確的3D模型、神經定位、鼻竇評估和引導式截骨術提供了支持。基於這些規劃創建的手術範本,可以將虛擬位置轉換為精確位置。這些步驟減少了手術過程中的變異性,並縮短了調整時間。雖然在中國,高昂的購置成本可能會減緩一般診所的採購速度,但這些技術的普及應用仍將持續。
牙科服務提供者數量增加。為滿足患者需求,牙科診所的數量正在增加。連鎖診所和專科醫院也在增加每日接診量和可進行的診療計畫範圍。整合有助於改善庫存管理、培訓和通訊協定標準化,從而提高病例處理效率並加快數位化工具的應用。
人們對美觀性的需求日益成長。植入被廣泛認為是單顆牙齒缺失的最佳修復方式,外觀和功能都與天然牙齒無異。隨著患者尋求能夠保護鄰近琺瑯質的固定修復方案,單顆牙齒缺失的病例正在迅速增加。這種變化推動了植入對於傳統牙橋的普及。
培訓和臨床醫生能力。透過供應商計畫、學術課程和連鎖研討會主導的研討會,植入教育的進步能夠提升臨床醫師的信心。隨著更多全科醫生累積經驗,診所可以將較簡單的病例納入診所內部處理,僅將最複雜的病例轉診給專科醫生,從而增加整體植入病例量。
市場限制
基於數量的採購和定價壓力。依量採購 (VBP)競標持續對平均售價 (ASP) 構成下行壓力。中標者可以獲得州內或全國範圍內的高市場佔有率,促使其降低價格。然而,單一供應商面臨利潤率壓力,必須調整其產品組合和服務模式才能保持競爭力。
改善口腔健康。改善口腔衛生可減少重大修復手術,從而減少因人口老化而導致的多部件和全口義齒治療數量增加,並提高每位患者的治療價值。
費用高昂且公共保險覆蓋範圍有限。像植入這樣的大型牙科手術不在公共保險的覆蓋範圍內。在中國,植入的自付費用(包括服務費)可能超過3000美元。這限制了許多家庭接受植牙,除非價值導向定價(VBP)和連鎖定價能夠降低總成本,否則需求將主要集中在都市區的中高所得人群中。
監管壁壘。中國的醫療設備法規要求獲得本地核准,包括提供國內臨床數據。外國製造商可能面臨更長的註冊時間。這可能會延遲其產品進入修復系統市場,並降低新型植入和支台齒設計的短期供應量。
目標市場和數據範圍
量化指標:市場規模、市佔率、市場預測、成長率、銷售量、平均售價。
定性報告:成長促進因素和阻礙因素、主要競爭對手的競爭分析和 SWOT 分析、併購、公司簡介和產品系列、技術和工作流程趨勢、影響定價和准入的政策環境。
時限:歷史資料 2021-2024 年,預測 2025-2031 年,基準年 2024 年。
資料來源:對產業領導者的初步訪談、政府和監管資料、醫院和連鎖機構的投入、進出口資料、iData Research 內部資料庫。
方法論收入模型為單位乘以平均售價,並透過固定單牙、牙橋和義齒應用的設定和治療配置的採用率進行檢驗。
目標市場及區隔
人工植牙市場
類型:高級、超值、折扣。
形狀:平行壁,錐形。
材質:鈦、陶瓷或氧化鋯。
治療類型:單階段、雙階段、即時負重。
連接類型:內部連接、外部連接、整合。
應用範圍:單顆牙齒應用、多牙橋部分牙弓固定、多牙橋全牙弓固定、義齒固定。
終末支台齒市場
加工製造。包括庫存零件、客製化鑄件、CAD 或 CAM 設計。
材質:鈦、陶瓷或氧化鋯、黃金。
類型:黏接式、螺絲固位式、義齒固位式。
儀器套件市場
治療計劃軟體市場
手術範本市場
競爭分析
2024年,最大的競爭對手是士卓曼集團。該品牌以其在高階植入的卓越業績和廣泛的植入相關產品組合而聞名。其價值品牌Neodent在價值型市場表現優異,並透過拓展更廣泛的臨床預算,鞏固了其整體市場佔有率。持續的併購活動拓寬了產品組合的適應症和材料範圍,幫助士卓曼在以價值為導向的植體和不斷擴張的連鎖店所主導的市場環境中保持領先地位。
2024年,歐斯汀植體在中國排名第二。該公司憑藉其與AIC網路合作的教育計畫以及涵蓋ET、MS和SS植入系統的產品組合而備受認可。歐斯汀不僅提供植入和支台齒產品,還提供一系列手術器械,包括再生產品、導板果凍系統和牙科椅。如此豐富的產品線有助於診所從單一供應商採購產品,並將培訓與產品使用相結合。
Envista 透過 Nobel Biocare 佔第三大市場佔有率。 NobelActive 和 NobelReplace 依賴強大的修復生態系統,包括 NobelProcera ASC支台齒和 OmniGrip 工具。 Envista 同時供應原廠支台齒和 CAD/CAM支台齒。儘管價格競爭依然激烈,但對於那些重視長期療效、優質服務和清晰數位化工作流程的牙科診所而言,Envista 仍然是首選。該公司進軍再生材料領域預計將進一步完善其植入組合。
其他參與企業則在區域和地方層級展開角逐,重點關注物流、分銷商關係以及為獨立診所提供的客製化支援。競爭對手的成功要素包括訓練能力、可靠的供貨能力、豐富的義肢產品目錄,以及在基於價值的定價(VBP)規則價格分佈同時支援高階和低價價格分佈的能力。
科技與臨床趨勢
錐形束CT(CBCT)和導板手術。 CBCT規劃和手術範本可提高植入精度,並減少修復體修復的需要。它們最常用於連鎖醫院和專科醫院。小型診所通常與外部實驗室合作進行設計和導板製作,以避免大筆設備購買。
內連接和錐形設計。內連接可提供假體穩定性並控制扭力。錐形植入可在各種骨質條件下提供初期穩定性,並且只要符合臨床標準,即可與即時或早期負重通訊協定相容。
材料選擇。鈦金屬仍然是強度和骨整合的標準材料。氧化鋯植入和支台齒則兼顧前牙美觀和無金屬偏好。當強度和美觀都至關重要時,可以選擇氧化鋯-鈦基混合支台齒設計。
傳統支台齒與CAD/CAM支台齒。鈦支台齒因其成本和易得性,在市場中佔主導地位。隨著連鎖機構和技工室不斷提升掃描和銑床能力,CAD/CAM支台齒的市佔率正在持續成長。客製化的基台輪廓能夠改善軟組織修復效果,並可實現螺絲固位修復體螺絲孔的精確對準。客製化鑄造支台齒則適用於傳統連接方式和特殊角度。
診所與實驗室的協作。治療效果的品質取決於與實驗室的密切合作,包括使用掃描體、設計牙齦輪廓和製定咬合計劃。植入鏈將這些步驟標準化,並使用了解植入庫和支台齒選擇的內部或優選實驗室。
地區
本期內容主要涉及中國。
中國植入和最終支台齒市場中最大、成長最快的機會是什麼?到 2031 年,供應商將如何調整價格分佈和供應商策略?
數位化如何改變日常工作流程,連鎖機構和實驗室不斷擴展其數位化能力:CBCT、規劃軟體、手術範本、掃描體、CAD 或 CAM支台齒等。
哪些支台齒形式將獲得市場佔有率?診所應如何平衡使用標準基台、客製化鑄造基台、CAD 基台或 CAM 基台來管理軟組織、咬合和螺絲孔徑,同時控制成本?
牙科服務機構將如何影響採購、培訓和品牌標準化?
VBP 將對診所經濟(包括病例量、椅位使用時間和返工)產生哪些實際影響?供應商如何設計套餐和教育方案來抵銷利潤壓力?
根據適應症和具體情況,應該如何使用螺絲固位式植體和骨水泥固位式植體?骨水泥的控制和取出通訊協定如何影響長期維護?
哪些監理措施最有可能延遲產品上市?海外製造商應如何應對申報、臨床證據和本地夥伴關係等階段,以縮短產品上市時間?
哪些風險可能會減緩成長,例如更積極的平均售價壓縮、小型診所數位化普及速度緩慢,以及大型連鎖機構尚未滲透的地區病患支付能力有限?
iDataResearch 的「中國人工植牙及最終支台齒市場報告」透過價格分佈模型、企業市場占有率分析以及對數位化和手術流程的清晰闡述,解答了這些問題。該報告可用於預測各類別的需求、在基於價值的定價 (VBP) 環境下制定定價策略、規劃產品藍圖,以及設計培訓和支持方案,從而在控制成本的同時改善治療效果。
圖表清單
圖表列表
調查方法
全球關稅的影響
中國人工植牙和最終支台齒市場
The China dental implant and final abutment market was valued at nearly 604 million dollars in 2024. The market is forecast to grow to more than 1.3 billion dollars by 2031.
This report suite covers dental implants, final abutments, treatment planning software, and surgical guides.
Quantitative coverage includes unit sales, average selling prices, market size, growth rates, and company shares.
Qualitative coverage includes market drivers and limiters, recent mergers and acquisitions, company profiles, product portfolios, and competitive positioning across dental chains, specialist hospitals, and independent clinics.
A major policy force in China is volume-based procurement (VBP). VBP seeks to lower out-of-pocket costs by consolidating demand into tenders that reward lower unit prices.
The short-term effect is ASP compression on implant fixtures and, to a lesser extent, on abutments tied to the winning ecosystems.
The medium-term view is more balanced. As tenders expand patient access and help clinics serve more cases, procedure volumes rise, which can offset price declines at the total market level.
Vendors that align portfolios, education, and service with VBP outcomes are best positioned to defend share while participating in higher volumes.
Market Overview
China's implant market brings together three forces. First is patient demand driven by aesthetics, function, and a large base of partially edentulous adults. Second is care delivery scale, with fast-growing dental service organizations and specialist dental hospitals expanding capacity and adding implant chairs. Third is policy and pricing, centered on VBP and on the goal of lowering the total cost of care without reducing quality.
On the clinical side, the core platform is a titanium fixture placed in bone and a final abutment that connects the fixture to the crown or prosthesis. Around this platform, adoption of CBCT imaging, computer-guided surgery, and CAD or CAM abutments is steady in leading urban centers and academic hubs. These tools improve accuracy, shorten chair time, and reduce remakes. They also require investment in scanners, software, and staff skills, which can slow adoption in smaller clinics that operate on tight budgets.
The structure of the buyer base matters. Private dental chains such as Arrail Dental Group, Bybo Dental Group, and Jiamei Dental Group are expanding their networks. Chains can standardize systems, negotiate better pricing, and run education programs across locations. Independent clinics focus on reliability, availability of parts, and support from local distributors. Specialist dental hospitals handle complex cases and train residents on advanced workflows that include guided surgery and custom abutments.
Market Drivers
Improved supporting technology. The rise of CBCT scanners and planning software supports accurate 3D models, nerve mapping, sinus assessment, and guided osteotomy. Surgical guides built from these plans translate virtual positions into precise placement. These steps lower variability and reduce adjustment time during restoration. China will see continued adoption, although capital costs can delay purchases at general practices.
Growth of dental service organizations. The number of dental care organizations is growing to meet patient demand. Chains and specialist hospitals expand the number of patients per day and the range of procedures they can perform. Consolidation allows better inventory control, training, and protocol standardization, which supports higher case throughput and faster adoption of digital tools.
Demand for improved aesthetics. Implants are widely regarded as the best single-tooth replacement for natural look and function. Single-tooth cases are growing quickly as patients seek fixed solutions that preserve adjacent enamel. This shift increases implant penetration relative to conventional bridges.
Training and clinician capability. Growth in implant education through vendor programs, academic courses, and chain-led workshops improves clinician confidence. As more general practitioners gain experience, clinics can internalize straightforward cases and refer only the most complex work to specialists, which increases total implant volumes.
Market Limiters
Volume-based procurement and price pressure. VBP tenders place continued downward pressure on ASPs. Winning bids can secure high unit share within a province or nationally, which motivates lower prices. Over time, volume gains can offset value losses at the market level, but individual vendors face margin pressure and must adapt portfolios and service models to remain competitive.
Improvements in dental health. Better oral health reduces the pool of severe restorative cases. This tempers growth from aging demographics and can lower the number of multi-unit and full arch treatments that would otherwise support higher value per patient.
Costs and limited public coverage. There is no public insurance coverage for major dental procedures like implants. Out-of-pocket costs for an implant case in China can be well over 3,000 dollars including services. This limits adoption for many households and concentrates demand in middle and upper income urban segments unless VBP and chain pricing lower total costs.
Regulatory barriers. China's medical device regulation requires local approvals that can include in-country clinical data. Foreign manufacturers may face longer registration timelines. This can delay entry for restorative systems and reduce the short-term availability of new implant and abutment designs.
Market Coverage and Data Scope
Quantitative coverage. Market size, market shares, market forecasts, growth rates, units sold, and average selling prices.
Qualitative coverage. Growth drivers and limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles and product portfolios, technology and workflow trends, and the policy environment that shapes pricing and access.
Time frame. Historical data 2021 to 2024, forecasts 2025 to 2031, base year 2024.
Data sources. Primary interviews with industry leaders, government and regulatory data, hospital and chain inputs, import and export data, and the iData Research internal database.
Method note. Revenues are modeled as units multiplied by ASP, validated with adoption rates by setting and procedure mix across single-tooth, bridge, and denture securement applications.
Markets Covered and Segmentation
Dental Implants Market
Type. Premium, value, discount.
Shape. Parallel wall, tapered.
Material. Titanium, ceramic or zirconia.
Procedure type. One-stage, two-stage, immediate loading.
Connection type. Internal connection, external connection, one-piece.
Application. Single-tooth application, multi-tooth bridge partial arch securement, multi-tooth bridge full arch securement, denture securement.
Final Abutment Market
Fabrication. Stock, custom cast, CAD or CAM.
Material. Titanium, ceramic or zirconia, gold.
Type. Cement-retained, screw-retained, denture retaining.
Instrument Kit Market
Treatment Planning Software Market
Surgical Guide Market
Competitive Analysis
Straumann Group was the leading competitor in 2024. The brand has strong recognition with a record of high performance in premium implants and a broad implant-associated portfolio. The Neodent value brand has outpaced the market in the value tier, which strengthens overall share by capturing a larger range of clinical budgets. Ongoing mergers and acquisitions enhance portfolio reach across indications and materials and help Straumann defend leadership in an environment shaped by VBP and expanding chains.
Osstem Implant ranked second in China in 2024. The company has achieved strong recognition through education programs with the AIC network and a portfolio that includes the ET, MS, and SS implant systems. Osstem complements its implant and abutment lines with regenerative products, guided surgery systems, and selected operatory equipment such as dental chairs. This breadth helps clinics source from a single vendor and align training with product use.
Envista held the third largest share through Nobel Biocare. NobelActive and NobelReplace are supported by a robust prosthetic ecosystem, including the NobelProcera ASC abutment and the Omnigrip tool. Envista supplies both stock abutments and CAD or CAM abutments. Persistent price pressure shapes competitive tactics, yet the brand remains a preferred choice where clinics prioritize long-term evidence, service, and a clear digital workflow. Expansion into regenerative materials is expected to complement the implant portfolio.
Other participants compete at regional and local levels with focus on logistics, distributor relationships, and tailored support for independent clinics. Success factors across competitors include training capacity, reliable supply, broad prosthetic catalogs, and the ability to support both premium and value price points under VBP rules.
Technology and Practice Trends
CBCT and guided surgery. CBCT planning and surgical guides improve placement accuracy and reduce the need for restorative corrections. Adoption is highest in chains and in specialist hospitals. Smaller clinics often work with external labs that provide design and guide fabrication to avoid large capital purchases.
Internal connections and tapered designs. Internal connections offer prosthetic stability and torque control. Tapered implants support primary stability in a wide range of bone qualities and fit immediate or early loading protocols when clinical criteria are met.
Material use. Titanium remains the fixture standard for strength and osseointegration. Zirconia implants and zirconia abutments serve anterior esthetics and metal-free preferences. Hybrid abutment designs pair zirconia with titanium bases when strength and esthetics both matter.
Stock versus CAD or CAM abutments. Stock titanium abutments lead in volume due to cost and availability. CAD or CAM abutments gain share as chains and labs scale scanning and milling. Custom contours improve soft tissue outcomes and allow precise alignment of screw access for screw-retained restorations. Custom cast abutments remain useful for legacy connections and unusual angulations.
Clinic to lab collaboration. Outcome quality depends on tight coordination with labs for scan body use, emergence profile design, and occlusal planning. Chains standardize these steps and use internal or preferred labs that understand implant libraries and abutment options.
Geography
This edition covers China.
Where is the largest and fastest growing opportunity in China's implant and final abutment market, and how will VBP reshape price corridors and vendor strategies through 2031.
How will digitization change everyday workflows, including the pull-through for CBCT, planning software, surgical guides, scan bodies, and CAD or CAM abutments as chains and labs scale digital capacity.
Which abutment formats will gain share, and how should clinics balance stock, custom cast, and CAD or CAM to manage soft tissue, occlusion, and screw access while controlling cost.
How will dental service organizations influence procurement, training, and brand standardization, and what does this mean for premium versus value systems.
What is the practical impact of VBP on clinic economics, including case volumes, chair time, and remakes, and how can vendors design bundles and education that offset margin pressure.
What is the right mix of screw-retained and cement-retained designs by indication and setting, and how do protocols for cement control and retrievability affect long term maintenance.
Where are regulatory steps most likely to delay launches, and how should foreign manufacturers stage submissions, clinical evidence, and local partnerships to reduce time to market.
What risks could slow growth, including more aggressive ASP compression, slower digital adoption at smaller clinics, and limits on patient ability to pay in regions without strong chain penetration.
The China Dental Implant and Final Abutment Market report from iData Research answers these questions with price-tier models, company share analysis, and a clear view of digital and surgical workflows. Use it to size demand by category, set pricing strategies for VBP environments, plan product roadmaps, and design training and support programs that improve outcomes while controlling cost.
Table Of Contents
List Of Figures
List Of Charts
Research Methodology
Impact Of Global Tariffs
China Dental Implant and Final Abutment Market